Table 3.
Effects of artificial sweeteners aspartame and acesulfame K in between-group comparison.
| Variables | ASB | MW | Between-Group Comparison (after ASB vs. after MW) |
|---|---|---|---|
| Difference at Baseline vs. 2 Weeks |
Difference at Baseline vs. 2 Weeks |
p Value | |
| Fasting glucose (mmol/L) | −0.044, 0.8 | 0.145, 0.65 | 0.17 |
| Fasting insulin (pmol/L) | −0.94, 6.29 | −0.13, 4.58 | 0.34 |
| Glucose AUC | 0.63, 2.92 | 0.18, 2.82 | 0.31 |
| Glucose iAUC | 0.39, 3.88 | −0.10, 2.9 | 0.86 |
| Insulin AUC | −8.38 ± 35.6 | 3.44 ± 40.1 | 0.17 |
| Insulin iAUC | 3.44 ± 40.1 | 0.07 ± 32.05 | 0.47 |
Normally distributed values presented as mean ± SD and p values were determined by paired t tests. Non-normally distributed variables (shown as medians and interquartile ranges) were log transformed; p values obtained by Wilcoxon signed-rank nonparametric tests as variables were non-normally distributed after log transformation; p values for fasting glucose (N = 34), fasting insulin (N = 32), glucose AUC (N = 34), glucose iAUC (N = 33), comparing differences at baseline vs. 2 weeks obtained from Wilcoxon signed-rank nonparametric tests; p values for insulin AUC (N = 30) and insulin iAUC (N = 31) comparing differences at baseline vs. 2 weeks obtained from paired t tests.